A Safety and Tolerability Study of NC410 in Subjects With Advanced or Metastatic Solid Tumors

NCT04408599 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
46
Enrollment
INDUSTRY
Sponsor class

Stopped Upon completion of the Phase 1 portion of the NC410 monotherapy trial, NextCure focused efforts on a combination trial of NC410 in solid tumors.

Conditions

Interventions

Sponsor

NextCure, Inc.